Drug consumption facility as part of a primary health care centre for problem drug users-Which clients are attracted?

International Journal of Drug Policy

Volumn 20, Issue 5, 2009, Pages 447-449

  Scherbaum, Norbert ^a   Specka, Michael ^a   Bombeck, Johannes ^b   Marrziniak, Baerbel ^b  

^a Rhine State Hospital   (Germany)

^b Suchthilfe Direkt   (Germany)

Author keywords

Drug consumption facility; Harm reduction; Injecting drug use; Opiate dependence

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DETOXIFICATION; DRUG DEPENDENCE TREATMENT; FEMALE; HARM REDUCTION; HEPATITIS C; HEROIN DEPENDENCE; HIGH RISK BEHAVIOR; HOSPITAL ADMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; MALE; METHADONE TREATMENT; OPIATE ADDICTION; PATIENT COUNSELING; PRIMARY HEALTH CARE; PRIORITY JOURNAL; PSYCHOSOCIAL CARE;

ADOLESCENT; ADULT; ATTITUDE; DRUG USERS; FEMALE; HUMANS; MALE; MIDDLE AGED; OPIOID-RELATED DISORDERS; PRIMARY HEALTH CARE; RISK-TAKING; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE-RELATED DISORDERS;

EID: 67651008981     PISSN: 09553959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugpo.2009.01.001     Document Type: Article

References (16)

1. Darke S., Ross J., Zador D., and Sunjic S. Heroin-related deaths in New South Wales, Australia, 1992-1996. Drug and Alcohol Dependence 60 (2000) 141-150
2. Dolan K., Kimber J., Fry C., Fitzgerald J., McDonald D., and Trautmann F. Drug consumption facilities in Europe and the establishment of supervised injecting centres in Australia. Drug and Alcohol Review 19 (2000) 337-346
3. Dubois-Arber F., and Benninghoff J.A. Typology of injection profiles of clients of a supervised drug consumption facility in Geneva, Switzerland. European Addiction Research 14 (2008) 1-10
4. EMCDDA (European Monitoring Centre for Drugs and Drug Addiction). European report on drug consumption rooms (2004), Office for Official Publications of the European Communities, Luxembourg
5. Green T.C., Hankins C., Palmer D., Boivin J.F., and Platt R. My place, your place, or a safer place: The intention among Montreal injecting drug users to use supervised injecting facilities (SIF). Canadian Journal of Public Health 95 (2004) 110-114
6. Gsellhofer B., Küfner H., Vogt M., and Weiler D. European Addiction Severity Index: EuropASI (1999), Schneider Verlag Hohengehren, Baltmannsweiler
7. Hathaway A.D., and Tousaw K.I. Harm reduction headway and continuing resistance: Insights from safe injection in the city of Vancouver. International Journal of Drug Policy 19 (2008) 11-16
8. Jones R., Gruer L., Gilchrist G., Seymour A., Black M., and Oliver J. Recent contact with health and social services by drug misusers in Glasgow who died of fatal overdose in 1999. Addiction 97 (2002) 1517-1522
9. Kimber J., and van Beek I. Consumption rooms-The Australian experience. Akzeptanz 10 2 (2002) 54-58
10. Kimber J., MacDonald M., van Beek I., Kaldor J., Weatherburn D., Lapsley H., et al. The Sydney Medically Supervised Injecting Centre: Client characteristics and predictors of frequent attendance during the first 12 months of operation. Journal of Drug Issues 33 (2003) 639-648
11. Scherbaum N., Reissner V., DiFuria L., Ghodse H., Kokkevi J., Rehm R., et al. Vergleich der Behandlungsnetze für Drogenabhängige in Europa - Das TREAT-Projekt (Comparison of the health care system for drug addicts in Europe - The TREAT-project). Nervenarzt 74 Suppl. 2 (2003) 268
12. Scherbaum N., Specka M., Hauptmann G., and Gastpar M. Does maintenance treatment reduce the mortality rate of opioid addicts?. Fortschritte der Neurologie-Psychiatrie 70 (2002) 455-461 (article in German)
13. Scherbaum N., and Specka M. Factors influencing the course of opiate addiction. International Journal of Methods in Psychiatric Research 17 (2008) S39-44
14. Specka, M. (2008). Muster des Beikonsums psychotroper Substanzen im Verlauf einer Methadonsubstitution (Patterns of concomitant psychotropic substance use during the course of methadone substitution treatment). Unpublished doctoral dissertation, Universität of Duisburg-Essen, Essen.
15. Strang J., McCambridge J., Best D., Beswick T., Bearn J., Rees S., et al. Loss of tolerance and overdose mortality after inpatient opiate detoxification: Follow up study. BMJ 326 (2003) 959-960
16. Wood E., Tyndall M.W., Li K., Lloyd-Smith E., Small W., Montaner J.S., et al. Do supervised injecting facilities attract higher-risk injection drug users?. American Journal of Preventive Medicine 29 (2005) 126-130